Precision oncology thinking — applied across prevention, survivorship, and blood health.
BioNurture is a board-certified, physician-led, membership-based practice for individuals who want expert, personalized guidance navigating cancer risk, life after cancer treatment (survivorship), and benign hematologic findings — with clarity and continuity over time.
Led by a board-certified oncologist and hematologist, BioNurture integrates precision oncology principles across all aspects of care, supported by AI-enabled systems that enhance — not replace — clinical judgment, ensuring decisions remain human-centered, evidence-based, and accountable.
Precision oncology thinking — applied across prevention, survivorship, and blood health.
The Gap BioNurture Solves
Modern medicine delivers more information than ever. What’s missing is expert guidance across time.
Patients at elevated cancer risk, cancer survivors, and individuals with abnormal blood findings are often offered testing without a clear strategy — or results without context.BioNurture exists to help patients:
Understand which tests matter
Decide when testing is appropriate — and when it is not
Interpret results accurately and longitudinally
Make informed decisions with a specialist who knows their full clinical picture.
This is not about more testing. It is about better decisions, over time.
How BioNurture Works
Longitudinal, physician-guided care — not one-time opinions
BioNurture provides an ongoing clinical partnership designed to evolve as your health, data, and life circumstances change.
We combine:
Board-certified oncology and hematology expertise
Precision oncology frameworks drawn from translational medicine
Thoughtfully integrated, AI-enabled tools that support continuity
The result is care that is personalized, evidence-based, and longitudinal — rather than fragmented or episodic.
Core Care Pathways
High-Risk Cancer Prevention
For individuals with genetic, familial, treatment-related, hematologic, or environmental risk factors who want to:
Clarify individualized cancer risk
Develop an evidence-based diagnostic and surveillance strategy
Use testing intentionally — avoiding unnecessary or harmful over-testing
Adjust plans as new evidence and personal risk factors evolve
Cancer Survivorship (After Treatment)
For cancer survivors who have completed active treatment and want to:
Longitudinal risk stratification and follow-up
Guidance interpreting surveillance labs and imaging
Support navigating late effects and long-term health considerations
A precision oncology framework applied beyond the treatment window
Benign Hematology & Blood Health
For individuals with abnormal or evolving blood findings who want to:
Clear interpretation of what results mean — and what they do not
Longitudinal monitoring plans grounded in evidence
Personalized recommendations rather than generic lab commentary
Ongoing guidance as trends evolve over time
Technology, Used Responsibly
AI-enabled to support care — never to replace clinicians
BioNurture uses advanced technology to organize records, track trends, and support continuityof care over time.
AI does not diagnose,treat, or make medical decisions.All medical guidanceand recommendations are provided by board-certified clinicians, ensuringaccountability, nuance, and patient safety.
Designed to complement — and in some cases serve as the primary specialty practice
BioNurture works alongside your broader medical care, including primary care physicians and, when applicable, comprehensive cancer centers.
For benign hematology, high-risk cancer prevention, and cancer survivorship, BioNurture may serve as the primary specialty practice, providing ongoing evaluation, monitoring, and management within scope.
BioNurture does not provide infusion chemotherapy, radiation therapy, or procedural oncology services.
For patients receiving active cancer treatment through a comprehensive cancer center, BioNurture partners with the treating oncology team to support prevention planning, survivorship strategy, and longitudinal decision-making.
In select, clinically appropriate situations, management of oral anticancer agents may be provided when within scope and determined on an individualized basis. Supportive infusions, such as IV iron, may be coordinated and administered through partner infusion centers when clinically indicated.
Membership Model
An intentional, limited-panel practice BioNurture operates asa membership-based medical practice.
We intentionally limit our panel to ensure:
Time for thoughtful review and interpretation
Continuity and responsiveness
A high-quality, trusted patient experience
Insurance & Billing Membership fees are not billed to insurance. Diagnostic testing and imaging maybe billed by third-party providers and may be covered subject to individualpayer policies.
Confidential Intake Review — We review your history, goals, and records.
Clinical Alignment — We determine fit for prevention, survivorship, or hematology guidance.
Clear Next Steps — If aligned, you receive personalized onboarding; if not, we guide you to appropriate resources.
Apply for Membership
Please complete the application below. Each inquiry is reviewed individually to ensure appropriate clinical alignment.
+ Important Notes
BioNurture is a physician-led medical practice providing longitudinal care for high-risk cancer prevention, cancer survivorship, and benign hematology.
BioNurture may serve as the primary specialty practice for prevention, survivorship, and benign hematologic conditions.
BioNurture does not provide infusion chemotherapy, radiation therapy, or procedural oncology services.
For patients undergoing active cancer treatment, BioNurture coordinates with thetreating oncology team and comprehensive cancer centers as appropriate.
In select, clinically appropriate cases, oral anticancer therapies may be managed within scope and on an individualized basis; supportive infusions (e.g., IV iron) may be coordinated through partner infusion centers.
BioNurture is not an emergency service. Inemergencies, call 911 or go to the nearest emergency department.
AI-enabledtools support care organization, longitudinal tracking, and continuity; they donot diagnose, treat, or make medical decisions. All medical guidance isprovided by board-certified clinicians.
Servicesare subject to state licensure and the establishment of an appropriateclinician–patient relationship.
BioNurture is led by Dr. Arisha Patel, MD, MBA, a board-certified oncologist and hematologist applying a precision oncology framework — grounded in evidence, ethics, and human judgment — to cancer risk, survivorship, and longitudinal blood health.
